Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3328325 | Acta Haematologica Polonica | 2014 | 8 Pages |
Abstract
The treatment was well tolerated. Most of the associated adverse events (AE) were mild and moderate (grade 1-2 according to CTCAE); only 5.6% of AE were considered as severe. Headache was the most common complication; whereas cauda equina syndrome was considered as potentially the most dangerous condition. Transient cauda equina syndrome was observed in 1 patient (2.8% of all AEs).
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Monika DÅugosz-Danecka, Wojciech Jurczak, Katarzyna Krawczyk, Agnieszka Giza, Aleksander B. Skotnicki,